Reviva Pharmaceuticals Holdings, Inc.

Tower Research Capital LLC (TRC) RVPH

Report date

9/30/2025

Quarter

2025 Q3

Filed

11/14/2025

Shares

22,417

Value ($000)

8

Weight

0.0%

2020 Q4 - 2025 Q3 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q3	11/14/2025	8	0.0%	22,417	9/30/2025
2025 Q2	8/15/2025	1	0.0%	1,424	6/30/2025
2025 Q1	5/15/2025	8	0.0%	8,247	3/31/2025
2024 Q4	2/13/2025	48	0.0%	26,775	12/31/2024
2024 Q3	11/14/2024	4	0.0%	2,822	9/30/2024
2024 Q2	8/13/2024	0	0.0%	390	6/30/2024
2023 Q4	2/13/2024	196	0.0%	38,043	12/31/2023
2023 Q2	8/14/2023	65	0.0%	11,109	6/30/2023
2023 Q1	5/9/2023	6	0.0%	1,519	3/31/2023
2022 Q4	2/10/2023	43	0.0%	10,037	12/31/2022
2022 Q3	11/10/2022	7	0.0%	4,271	9/30/2022
2022 Q2	8/15/2022	8	0.0%	6,905	6/30/2022
2022 Q1	5/12/2022	1	0.0%	440	3/31/2022
2021 Q4	2/14/2022	11	0.0%	3,826	12/31/2021
2021 Q2	8/16/2021	61	0.0%	12,484	6/30/2021
2021 Q1	5/17/2021	12	0.0%	2,076	3/31/2021
2020 Q4	2/16/2021	1	0.0%	60	12/31/2020